0001209191-23-018385.txt : 20230314
0001209191-23-018385.hdr.sgml : 20230314
20230314141350
ACCESSION NUMBER: 0001209191-23-018385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yacob Ezra Y
CENTRAL INDEX KEY: 0001724997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09743
FILM NUMBER: 23730248
MAIL ADDRESS:
STREET 1: 1111 BAGBY
STREET 2: SKY LOBBY 2
CITY: HOUSTON
STATE: TX
ZIP: 77002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EOG RESOURCES INC
CENTRAL INDEX KEY: 0000821189
STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS [1311]
IRS NUMBER: 470684736
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 BAGBY, SKY LOBBY 2
CITY: HOUSTON
STATE: TX
ZIP: 77002
BUSINESS PHONE: 7136517000
MAIL ADDRESS:
STREET 1: 1111 BAGBY, SKY LOBBY 2
CITY: HOUSTON
STATE: TX
ZIP: 77002
FORMER COMPANY:
FORMER CONFORMED NAME: ENRON OIL & GAS CO
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-10
0
0000821189
EOG RESOURCES INC
EOG
0001724997
Yacob Ezra Y
1111 BAGBY, SKY LOBBY 2
HOUSTON
TX
77002
1
1
0
0
Chairman & CEO
Common Stock
2023-03-10
4
M
0
15870
96.29
A
126039.357
D
Common Stock
2023-03-10
4
D
0
13410
113.96
D
112629.357
D
Common Stock
2023-03-10
4
F
0
968
113.96
D
111661.357
D
Common Stock
2023-03-10
4
M
0
9029
75.09
A
120690.357
D
Common Stock
2023-03-10
4
D
0
5950
113.96
D
114740.357
D
Common Stock
2023-03-10
4
F
0
1212
113.96
D
113528.357
D
Common Stock
2023-03-10
4
M
0
6013
37.44
A
119541.357
D
Common Stock
2023-03-10
4
D
0
1976
113.96
D
117565.357
D
Common Stock
2023-03-10
4
F
0
1589
113.96
D
115976.357
D
Common Stock
2023-03-10
4
M
0
3190
49.86
A
119166.357
D
Common Stock
2023-03-10
4
D
0
1396
113.96
D
117770.357
D
Common Stock
2023-03-10
4
F
0
706
113.96
D
117064.357
D
Common Stock
2023-03-10
4
M
0
12725
81.81
A
129789.357
D
Common Stock
2023-03-10
4
D
0
9136
113.96
D
120653.357
D
Common Stock
2023-03-10
4
F
0
1412
113.96
D
119241.357
D
Stock Appreciation Rights
96.29
2023-03-10
4
M
0
15870
0.00
D
2018-09-25
2024-09-25
Common Stock
15870
0
D
Stock Appreciation Rights
75.09
2023-03-10
4
M
0
9029
0.00
D
2020-09-26
2026-09-26
Common Stock
9029
0
D
Stock Appreciation Rights
37.44
2023-03-10
4
M
0
6013
0.00
D
2021-09-28
2027-09-28
Common Stock
6013
3016
D
Stock Appreciation Rights
49.86
2023-03-10
4
M
0
3190
0.00
D
2022-01-04
2028-01-04
Common Stock
3190
1600
D
Stock Appreciation Rights
81.81
2023-03-10
4
M
0
12725
0.00
D
2022-09-27
2028-09-27
Common Stock
12725
25489
D
The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.
The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock.
The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock.
The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the January 4, 2021 date of grant. The SARs granted will become fully exercisable on January 4, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.
The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock.
Christina K. Byrom, attorney-in-fact for Ezra Y. Yacob
2023-03-14